visiongain Logo.png
Viral Vectors and Plasmid DNA Manufacturing market is projected to grow at a CAGR of 18.09% by 2032: Visiongain Reports Ltd
23 déc. 2022 06h00 HE | Visiongain Reports Ltd
Visiongain has published a new report entitled Viral Vectors and Plasmid DNA Manufacturing 2022-2032. It includes profiles of Viral Vectors and Plasmid DNA Manufacturing and Forecasts Market...
visiongain Logo.png
Gene therapy R&D market is projected to grow at a CAGR of 30.1% by 2032: Visiongain Reports Ltd
29 nov. 2022 12h29 HE | Visiongain Reports Ltd
Visiongain has published a new report entitled Gene Therapy R&D 2022-2032. It includes profiles of Gene Therapy R&D and Forecasts Market Segment by Disease {Cancer, Rare Diseases (Oncologic,...
visiongain Logo.png
Viral Vectors and Plasmid DNA Manufacturing market is projected to grow at a CAGR of 18.09% by 2032: Visiongain Reports Ltd
27 oct. 2022 07h51 HE | Visiongain Reports Ltd
Visiongain has published a new report entitled Viral Vectors and Plasmid DNA Manufacturing 2022-2032. It includes profiles of Viral Vectors and Plasmid DNA Manufacturing and Forecasts Market Segment...
visiongain Logo.png
Gene therapy R&D market is projected to grow at a CAGR of 30.1% by 2032: Visiongain Reports Ltd
19 sept. 2022 06h00 HE | Visiongain Reports Ltd
Visiongain has published a new report entitled Gene Therapy R&D 2022-2032. It includes profiles of Gene Therapy R&D and Forecasts Market Segment by Disease {Cancer, Rare Diseases (Oncologic,...
visiongain Logo.png
Global Gene Therapy R&D Market Worth US$ 22,685.70 million by 2031: Visiongain Reports Ltd
05 sept. 2022 07h08 HE | Visiongain Reports Ltd
Global Gene Therapy R&D Market Forecast 2021-2031: - Market Segment by Disease {Cancer, Rare Diseases (Oncologic, Non-Oncologic), Cardiovascular Diseases, Ophthalmic Diseases, Hematology,...
visiongain Logo.png
Global Gene Therapy R&D Market Worth US$ 22,685.70 Million by 2031: Visiongain Research Inc.
29 juin 2021 11h36 HE | Visiongain Ltd
Global Gene Therapy R&D Market Forecast 2021-2031: - Market Segment by Disease {Cancer, Rare Diseases (Oncologic, Non-Oncologic), Cardiovascular Diseases, Ophthalmic Diseases, Hematology,...